ImmunoPrecise Antibodies Ltd. (IPA) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find ImmunoPrecise Antibodies Ltd. (IPA) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest IPA stock news and headlines.
1 Month Prediction
$2.00 [278.99%]
3 Month Prediction
$1.15 [117.56%]
6 Month Prediction
$1.00 [89.21%]
1 Year Prediction
$1.00 [89.21%]
3 Year Prediction
$1.00 [89.21%]
5 Year Prediction
$1.00 [89.21%]
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. (IPA) is a biotechnology company incorporated in 2016 and headquartered in Victoria, British Columbia, Canada. The company develops therapeutic antibodies by utilizing multi-omics modeling and artificial intelligence. It also offers an integrated end-to-end suite of services, which includes custom antigen modeling, B cell sorting, phage display library production, and hybridoma development.
The company operates several subsidiaries - Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd., and ImmunoPrecise Antibodies (Europe) B.V.
The company employs around 102 people and has been recognized for its innovative approaches in antibody development. In particular, its LENS ai™ platform is designed to speed up antibody discovery through computational modeling.
ImmunoPrecise Antibodies Ltd. (IPA) Historical Performance
IPO Date
ImmunoPrecise Antibodies Ltd. (NGM:IPA) went public on 03 January, 2017.
Change
Since inception, IPA has decreased by 91.19%. In the last 5 years, IPA has fallen from $2.60 to $0.53, a massive -79.67% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $17.00 and a low of $0.38.
52 Week Range
$0.325
$2.6
The current price $0.53 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
IPA Stock Price History
Based on IPA stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the IPA stock has fallen from $2.15 - $14.95 to $0.53 - $0.53, which is down -78.53%. Currently, the stock follows downward trend.
Here, we have calculated stock range of IPA, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $2.15 - $14.95 | $6.18 | 150.34 | 1 Year Change |
| 2021 | $5.36 - $17.0 | $8.5 | 244.32 | 2 Year Change |
| 2022 | $3.8 - $6.18 | $5.0 | 102.54 | 3 Year Change |
| 2023 | $1.57 - $4.4 | $2.64 | 6.94 | 4 Year Change |
| 2024 | $0.38 - $1.85 | $1.0 | -59.49 | 5 Year Change |
| 2025 | $0.53 - $0.53 | $0.53 | -78.53 | 6 Year Change |
IPA Price Performance
6-Month Performance
IPA stock dropped by 30.00% in the last six months.
1-Year Performance
The stock has trended downwards by 71.36% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 89.28%.
5-Year Performance
In the last 5 years, the stock has gone down by 79.67%.
According to ImmunoPrecise Antibodies Ltd.'s historical data, below graph gives us the exact picture of how the IPA stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
579.55% ↑
2021
64.15% ↓
2022
2.80% ↓
2023
67.18% ↓
2024
75.91% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
ImmunoPrecise Antibodies Ltd. (IPA) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $6.12 M (Q4)
Revenue for Q4 ending 31st October, 2024 increased 16.38% compared to Q3 ending 31st July, 2024.
Annual Revenue: $24.07 M (1Y)
Revenue for trailing 12 months decreased 1.84% year over year from 30th April, 2024.
Market Capitalization
ImmunoPrecise Antibodies Ltd. has a market capitalization of $16.42M, which places IPA in the nano-cap category.
Fundamental Analysis
EPS: $-0.09 (Q4), $-1.06 (1Y)
EPS decreased 40.00% since last quarter, and decreased 0.93% since last year.
Net Income: $-2.55 M (Q4), $-27.18 M (1Y)
Net Income decreased 36.16% since last quarter, and increased 2.32% since last year.
Free Cash Flow: $-2.31 M (Q4), $-5.64 M (1Y)
Free Cash Flow increased 10.59% since last quarter, and decreased 73.54% since last year.
Net Profit Margin: -41.68% (Q4), -112.92% (1Y)
Net Profit Margin decreased 45.14% since last quarter, and increased 4.24% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for IPA stock. These indicators help you understand ImmunoPrecise Antibodies Ltd.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for IPA stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.44 |
| SMA50 | $0.43 |
| SMA200 | $0.82 |
| RSI | 70.69 |
| Beta | 0.27 |
SMA20 < Current Price
This signals IPA stock is in short-term bullish momentum.
SMA50 < Current Price
This signals IPA stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals IPA stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for IPA stock is Bearish. Out of all indicators, 3 indicates bullish signals, 4 signals bearish trends and 2 gives neutral trends. The IPA stock forecast was last updated on 12 January, 2025.
ImmunoPrecise Antibodies Ltd. (IPA) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $1.00 by the end of 2025, and can reach around $2.04 to $1.06 in 2026. And, the long-term forecast suggests that the stock may further jump to $1.00 - $0.84 in 2028, and $1.20 - $1.11 by 2031. So, the IPA stock shows a strong upward trend in the next several years.
Short-term IPA Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $2.00 | 278.43% |
| 2025-03 | $1.52 | 187.61% |
| 2025-04 | $1.15 | 117.6% |
| 2025-05 | $1.00 | 89.21% |
| 2025-06 | $1.00 | 89.21% |
| 2025-07 | $1.00 | 89.21% |
| 2025-08 | $1.00 | 89.21% |
| 2025-09 | $1.00 | 89.21% |
| 2025-10 | $1.00 | 89.21% |
| 2025-11 | $1.00 | 89.21% |
| 2025-12 | $1.00 | 89.21% |
In 2025, the IPA stock price is expected to fluctuate between $1.0 and $2.0. According to the monthly forecast, the stock could rise to $1.00 by December 2024. If compared to the IPA's current price, the stock could gain 89.21% by the end of this year.
Long-term IPA Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $2.04 | $0.73 | $1.06 | 100.57% |
| 2027 | $1.00 | $1.36 | $0.86 | 62.72% |
| 2028 | $1.00 | $0.98 | $0.84 | 58.94% |
| 2029 | $0.93 | $1.13 | $0.95 | 79.75% |
| 2030 | $1.11 | $1.03 | $1.09 | 106.24% |
| 2031 | $1.20 | $1.14 | $1.11 | 110.03% |
| 2032 | $1.01 | $1.07 | $0.88 | 66.51% |
| 2033 | $0.71 | $1.00 | $1.28 | 142.19% |
| 2034 | $1.02 | $0.92 | $1.00 | 89.21% |
| 2035 | $1.17 | $0.87 | $0.61 | 15.42% |
| 2036 | $1.01 | $1.07 | $1.01 | 91.11% |
| 2037 | $0.85 | $0.83 | $0.79 | 49.48% |
| 2038 | $0.84 | $0.89 | $1.22 | 130.84% |
| 2039 | $0.85 | $0.75 | $0.88 | 66.51% |
| 2040 | $1.06 | $0.71 | $0.96 | 81.65% |
| 2041 | $0.71 | $0.99 | $0.92 | 74.08% |
| 2042 | $1.01 | $0.97 | $1.22 | 130.84% |
| 2043 | $0.70 | $1.01 | $1.17 | 121.38% |
| 2044 | $1.11 | $0.87 | $0.74 | 40.02% |
| 2045 | $0.76 | $0.88 | $0.94 | 77.86% |
| 2046 | $1.21 | $0.96 | $0.89 | 68.4% |
| 2047 | $1.25 | $1.12 | $0.79 | 49.48% |
| 2048 | $0.95 | $1.09 | $0.82 | 55.16% |
| 2049 | $0.94 | $1.02 | $1.10 | 108.14% |
| 2050 | $1.15 | $0.69 | $0.76 | 43.8% |
| 2051 | $1.20 | $0.79 | $0.89 | 68.4% |
ImmunoPrecise Antibodies Ltd. (IPA) Stock Price Prediction & Forecast 2025
At the start of 2025, the IPA stock was at $0.53. Today, it is trading at $0.53, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $1.00 by December 2025 with a 89.21% change.
ImmunoPrecise Antibodies Ltd. (IPA) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the IPA stock. During this period, the IPA's price is forecasted to shift from $2.04 to $1.09, which is -46.57% loss.
In 2026, the stock would possibly open at $2.04, descends to $0.73 by mid-year, and wraps up at $1.06, reflecting a 99.83% increase from today's price. Further moving to 2030, the stock can kick off the year at $1.11, drop to $1.03 by mid-year, and finish at $1.09, which is 106.01% change from current price.
ImmunoPrecise Antibodies Ltd. (IPA) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.20 to $0.96, which is down 110.46%
In 2031, we can expect IPA to fluctuate between $1.11 and $1.20, a shift indicating a 110.46% gain by year-end compared to current price. And Until 2040, IPA can likely vary from $0.96 to $1.06. By the end of 2040, the stock could record a 82.18% rise from today's stock price.
ImmunoPrecise Antibodies Ltd. (IPA) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the IPA stock can see an an upturn from $0.71 to $0.76 in this period. In 2041, the stock can experience a high of $0.99 by mid-year, closing the year at $0.92. This results in a 87.97% increase from today.
Moving towards the end of 2050, IPA is projected to open the year at $1.15. The stock may dip to $0.69 during mid-year and finish the year at $0.76. Compared to the stock's current price, this translates to an overall gain of 43.74% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
IPA Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | - | $42.25 | 1.61% ▲ | $304.87 ▲ |
| NVAX | Novavax, Inc. | - | $9.31 | 15.86% ▲ | $74.57 ▲ |
| HOTH | Hoth Therapeutics, Inc. | - | $2.47 | 0.00% ▼ | -23.28 ▼ |
| SANA | Sana Biotechnology, Inc. | - | $4.49 | -0.11% ▼ | $225.59 ▲ |
| NRXP | NRx Pharmaceuticals, Inc. | - | $4.52 | 0.00% ▼ | -12.84 ▼ |
Last updated Jan 12 at 10:06 AM
IPA : Buy, Sell Or Hold?
Analyst Ratings
Based on 2 analysts, 2 rated as a strong buy, 0 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for IPA stock is Buy.
Expert Analysis
According to IPA short-term and long-term forecast, ImmunoPrecise Antibodies Ltd. shares are projected to go up by 43.8%, and reach a value of $0.76 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, IPA has recorded 10/30 green days, which reflects a 50.0% positivity rate with a price volatility of 0.05%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that IPA stock is undervalued. So, Based on IPA prediction and analysis, it may be the best time to hold IPA stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "IPA” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.
